Internal Reference Number: FOI_9206
Date Request Received: 04/02/2026 00:00:00
Date Request Replied To: 17/02/2026 00:00:00
This response was sent via: By Email
Request Summary: High-cost drugs in ophthalmology
Request Category: Private Individuals
| Question Number 1: I am researching the usage of high-cost drugs in ophthalmology. For the 4 months from September to December 2025, how many unique* patients received the following intra-vitreal treatments for any eye condition: Aflibercep Bevacizumab Brolucizumab Dexamethasone Faricimab Ranibizumab Fluocinolone acetonide *Please count a patient only once for any treatment, regardless of how many injections or implants they may have received | |
| Answer To Question 1: Please see our response in the spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below:  13510 - FOI_9206 - High cost drugs in Ophthalmology.xlsx | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
